JohnWendellCraytonMD

PubMed

• Lower frequency of antidepressant use in patients on renin-angiotensin-aldosterone system modifying medications.
  Nasr, S. J., Crayton, J. W., Agarwal, B., Wendt, B., Kora, R.> ;Cellular and molecular neurobiology. 2011 Feb 9
• Multimodality imaging in a depressed patient with violent behavior and temporal lobe seizures.
  Teresa Poprawski, A. N. Pluzyczka, Y. Park, V. N. Chennamchetty, Angelos Halaris, John W. Crayton, Lukasz M. Konopka> ;Clinical Eeg and Neuroscience. 2007 Jul 1
• 22 citations
  Fluoxetine, smoking, and history of major depression: A randomized controlled trial
  Bonnie Spring, Neal Doran, Sherry L. Pagoto, Dennis E. McChargue, Jessica Werth Cook, Katherine C. Bailey, John W. Crayton, Donald Hedeker> ;Journal of Consulting and Clinical Psychology. 2007 Feb 1
• Similar or disparate brain patterns? The intra-personal EEG variability of three women with multiple personality disorder.
  A.R. Lapointe, John W. Crayton, Robert A. deVito, Christopher G. Fichtner, Lukasz M. Konopka> ;Clinical Eeg and Neuroscience. 2006 Jul 1
• 2 citations
  Selective numbing and hyperarousal in male and female Bosnian refugees with PTSD.
  Spahic-Mihajlovic, A., Crayton, J. W., Neafsey, E. J.> ;Journal of anxiety disorders. 2005 Feb 22
• Double-blind trial of the effects of tryptophan depletion on depression and cerebral blood flow in smokers
  Michele L. Pergadia, Bonnie Spring, Lukasz M. Konopka, Barbara Twardowska, Parvez Shirazi, John W. Crayton> ;Addictive Behaviors. 2004 Jun 1
• 2 citations
  Biochemical and psychiatric predictors of Li(+) response and toxicity in Li(+)-treated bipolar patients.
  Layden, B. T., Minadeo, N., Suhy, J., Abukhdeir, A. M., Metreger, T., Foley, K., Borge, G., Crayton, J. W., Bryant, F. B., de Freitas, D. M.> ;Bipolar disorders. 2004 Mar 6
• Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report.
  Ghassan Aldurra, John W. Crayton> ;Journal of Clinical Psychopharmacology. 2001 Jun 1
• Changes in regional cerebral blood flow after electroconvulsive therapy for depression.
  Thomas Milo, Gary Kaufman, W.E. Barnes, Lukasz M. Konopka, John W. Crayton, Joseph G. Ringelstein, Parvez Shirazi> ;Journal of Ect. 2001 Mar 1
• Individual differences among cocaine users.
  E.Dı́anna Gunnarsdóttir, Regina Pingitore, Bonnie Spring, Lukasz M. Konopka, John W. Crayton, Tom Milo, Parvez Shirazi> ;Addictive Behaviors. 2000 Sep 1
• Platelet cytosolic calcium hyperresponsivity to serotonin in patients with hypertension and depressive symptoms.
  John Stephen M Delisi, Lukasz M. Konopka, Karen Russell, Francine L O’Connor, Richard S. Cooper, John W. Crayton> ;Biological Psychiatry. 1999 Apr 15
• Platelet Cytosolic Calcium Responses to Serotonin in Depressed Patients and Controls: Relationship to Symptomatology and Medication
  Stephen M Delisi, Lukasz M. Konopka, Francine L O’Connor, John W. Crayton> ;Biological Psychiatry. 1998 Mar 1
• Pathological gambling in hospitalized substance abusing veterans.
  Amin N. Daghestani, Eileen Elenz, John W. Crayton> ;The Journal of Clinical Psychiatry. 1996 Aug 1
• Effect of corticosterone on serotonin and catecholamine receptors and uptake sites in rat frontal cortex
  John W. Crayton, Ira Joshi, Anil Gulati, Ramesh C. Arora, William A. Wolf> ;Brain Research. 1996 Jul 29
• Cocaine and Metabolites in Human Graying Hair: Pigmentary Relationship
  Ralston W. Reid, Francine L. O'Connor, Alyce G. Deakin, Delores M. Ivery, John W. Crayton> ;Clinical Toxicology. 1996 Jan 1
• Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: Associated clinical features
  Christopher G. Fichtner, Francine L. O'Connor, Hock C. Yeoh, Ramesh C. Arora, John W. Crayton> ;Life Sciences. 1995 Jun 2
• Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients.
  Lukasz M. Konopka, Richard S. Cooper, John W. Crayton> ;Biological Psychiatry. 1995 May 1
• Production of nitric oxide and transforming growth factor-β in developing and adult rat brain
  M. Rita I. Young, Tatyana Farietta, John W. Crayton> ;Mechanisms of Ageing and Development. 1995 Apr 14
• Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: Preliminary observations on a possible predictor of clinical treatment res...
  Christopher G. Fichtner, Ramesh C. Arora, Francine L. O'Connor, John W. Crayton> ;Life Sciences. 1994 Jan 1
• The In Vitro Differential Binding of Benzoylecgonine to Pigmented Human Hair Samples
  Ralston W. Reid, Francine L. O'Connor, John W. Crayton> ;Clinical Toxicology. 1994 Jan 1
• Current pharmacotherapies for cocaine abuse: a review.
  Craig S. Tutton, John W. Crayton> ;Journal of Addictive Diseases. 1993 Mar 30
• Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin
  Anil Gulati, Ramesh C. Arora, John W. Crayton> ;European Journal of Pharmacology. 1993 Feb 9
• Aging and 3H-paroxetine binding in rat brain: effect of imipramine and tetrahydroacridine.
  Ramesh C. Arora, Anil Gulati, John W. Crayton> ;Life Sciences. 1993 Jan 1
• Paroxetine binding in the blood platelets of post-traumatic stress disorder patients
  Ramesh C. Arora, Christopher G. Fichtner, Francine L. O'Connor, John W. Crayton> ;Life Sciences. 1993 Jan 1
• Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin.
  Joseph L. Kut, M. Rita I. Young, John W. Crayton, Mark A. Wright, Mel E. Young> ;Immunopharmacology and Immunotoxicology. 1992 Jan 1
• Join now to see all